TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14742225

Group type: EXPERIMENTAL
Intervention: Sulfadiazine 2,000 mg administered twice daily (BID)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sulfadiazine 1,000 mg administered four times a day (QID)
Number of subjects: 8
Study: 11372002

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 1200 mg/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg/day
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 9040124

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg s.c.)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8494582

Group type: EXPERIMENTAL
Intervention: tromantadine hydrochloride (ViruMerz Serol)
Number of subjects: 198

Group type: COMPARATOR
Intervention: aciclovir
Number of subjects: 198
Study: 3137067

Group type: EXPERIMENTAL
Intervention: Glyceryl trinitrate (GTN)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 95
Study: 30244294

Group type: EXPERIMENTAL
Intervention: Prophylactic cholecystectomy (PC) during gastrectomy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard gastric surgery only (Control)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Prophylactic cholecystectomy (PC)
Number of subjects: 130
Study: 28481338

Group type: EXPERIMENTAL
Intervention: Glutinous brown rice (GBR) twice a day for 8 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: White rice (WR)
Number of subjects: 16
Study: 25134853

Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis (AFO)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No ankle-foot orthosis (without AFO)
Number of subjects: 15
Study: 21887811

Group type: EXPERIMENTAL
Intervention: Internet intervention (unguided self-help intervention with a depression information website and automated cognitive behavioural therapy)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Waiting list control group (free to access formal or informal help as usual)
Number of subjects: 163
Study: 22987692

Group type: EXPERIMENTAL
Intervention: Assisted 6-minute cycling test (A6MCT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: 6-minute walk test (6MWT)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Motor Function Measure (MFM)
Number of subjects: 129
Study: 19447767

Group type: EXPERIMENTAL
Intervention: Glucocorticoid therapy (prednisolone or equivalent)
Number of subjects: 689
Study: 17590199

Group type: EXPERIMENTAL
Intervention: Hypothermia (33-34 degrees C) for 72 hours
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 21
Study: 15384026

Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg daily for 4 weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Enalapril 10 mg daily for 4 weeks
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both drugs (Candesartan and Enalapril)
Number of subjects: 29
Study: 11755415

Group type: EXPERIMENTAL
Intervention: Experimental challenges with pathogenic Salmonella enterica serovar Typhi
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Large-scale controlled field trials
Number of subjects: 0
Study: 11477909

Group type: EXPERIMENTAL
Intervention: Photo-acupuncture (101 cases)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Ear-pressing (101 cases)
Number of subjects: 202
Study: 7799392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various agents (gold injections, D-penicillamine, auranofin, antimalarials, azathioprine, sulfasalazine, methotrexate)
Number of subjects: 0
Study: 3259099

Group type: EXPERIMENTAL
Intervention: Intravenous propofol as a bolus followed by continuous infusion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus of thiopentone followed by maintenance with enflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 29050464

Group type: EXPERIMENTAL
Intervention: Epigallocatechin-3-gallate (EGCG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no anti-platelet medication)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aspirin (ASA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clopidogrel (CPD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ticagrelor (TCG)
Number of subjects: 40
Study: 28947466

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) 1010 colony-forming units twice a day for 5 days
Number of subjects: 970

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 970

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG)
Number of subjects: 970
Study: 26004768

Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 835
Study: 23313101

Group type: EXPERIMENTAL
Intervention: Post-absorptive exercise
Number of subjects: 12

Group type: COMPARATOR
Intervention: Postprandial exercise
Number of subjects: 12
Study: 21497140

Group type: EXPERIMENTAL
Intervention: Cathodal‐SO
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Anodal‐SO
Number of subjects: 30

Group type: COMPARATOR
Intervention: M1-extracephalic montage
Number of subjects: 30

Group type: COMPARATOR
Intervention: SO-extracephalic montage
Number of subjects: 30
Study: 18489937

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) with or without medroxyprogesterone acetate (MPA)
Number of subjects: 978
Study: 17165301

Group type: EXPERIMENTAL
Intervention: Low cement thickness (group 1) with size 3 FRC posts cemented using adhesive plus resin cement
Number of subjects: 18

Group type: COMPARATOR
Intervention: High cement thickness (group 2) with size 1 FRC posts cemented as in group 1
Number of subjects: 18
Study: 14733469

Group type: EXPERIMENTAL
Intervention: Commercial breath analyzer (CBA) measuring volatile sulfur compounds (VSCs) before and after tongue debridement
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Organoleptic methods for breath odor evaluation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Frequency of tooth-brushing
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Detection of breath odor by mother and OBJ
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Detection of breath odor by evaluators and CBA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Presence of interproximal restorations
Number of subjects: 30
Study: 10799380

Group type: EXPERIMENTAL
Intervention: Sunflower oil meal with beta-carotene (47 micromol)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Beef tallow meal with beta-carotene (47 micromol)
Number of subjects: 11
Study: 8817983

Group type: EXPERIMENTAL
Intervention: Nikkiso Centrifugal Pump (HPM15)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Roller Pump (RP)
Number of subjects: 14
Study: 1450043

Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Plicamycin
Number of subjects: 48
Study: 3933675

Group type: COMPARATOR
Intervention: Olsalazine 1 g as a retention enema nightly for two weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral olsalazine 2 g daily for two weeks
Number of subjects: 100
Study: 31199694

Group type: EXPERIMENTAL
Intervention: Active Videogames (AVG)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE) + Active Videogames (AVG)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Aerobic Exercise (AE)
Number of subjects: 49
Study: 29325427

Group type: EXPERIMENTAL
Intervention: Home visitation (HV) intervention
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual care services from child protection (Control)
Number of subjects: 122
Study: 27090500

Group type: EXPERIMENTAL
Intervention: Preventure program
Number of subjects: 438

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 438
Study: 23698186

Group type: EXPERIMENTAL
Intervention: Aliskiren (150-300 mg/d) and Valsartan (160 mg/d)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Aliskiren (150-300 mg/d)
Number of subjects: 52
Study: 22539602

Group type: EXPERIMENTAL
Intervention: Rotating night shift work
Number of subjects: 640

Group type: COMPARATOR
Intervention: Day shift work (Control)
Number of subjects: 640
Study: 20443741

Group type: EXPERIMENTAL
Intervention: Lip muscle training with an oral screen
Number of subjects: 67

Group type: COMPARATOR
Intervention: Healthy subjects (no intervention mentioned)
Number of subjects: 67
Study: 17509852

Group type: EXPERIMENTAL
Intervention: Flunisolide (inhaled twice a day for 4 weeks)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (inhaled twice a day for 4 weeks)
Number of subjects: 13
Study: 15257185

Group type: EXPERIMENTAL
Intervention: Candesartan 8-16 mg once daily
Number of subjects: 2098

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2098
Study: 11427285

Group type: EXPERIMENTAL
Intervention: 2.5 microg dose of hepatitis B vaccine
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 10 microg dose of hepatitis B vaccine
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (baseline anti-HBs levels)
Number of subjects: 59
Study: 9849709

Group type: EXPERIMENTAL
Intervention: Glucocorticoid receptors in peripheral mononuclear leukocytes (MNL) of PCOS patients
Number of subjects: 10

Group type: COMPARATOR
Intervention: Glucocorticoid receptors in peripheral mononuclear leukocytes (MNL) of healthy women (controls)
Number of subjects: 10
Study: 8002670

Group type: EXPERIMENTAL
Intervention: Oral potassium citrate therapy (600 mEq/day)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Untreated cases with lithiasis
Number of subjects: 119
Study: 2507028

Group type: EXPERIMENTAL
Intervention: Dietary treatment (weight reduction, sodium restriction, decreased alcohol intake)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Drug treatment (atenolol as first choice)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Dietary treatment
Number of subjects: 61

Group type: COMPARATOR
Intervention: Drug treatment
Number of subjects: 61
Study: 1256730

Group type: EXPERIMENTAL
Intervention: Intraamniotic prostaglandin F2alpha (PGF2alpha) and intracervical laminaria
Number of subjects: 116

Group type: COMPARATOR
Intervention: Prostaglandin F2alpha (PGF2alpha) only
Number of subjects: 116
Study: 31228196

Group type: EXPERIMENTAL
Intervention: Tobacco Tactics (nurse-delivered inpatient smoking cessation intervention)
Number of subjects: 1370

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1370
Study: 30537271

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sucrose
Number of subjects: 0
Study: 27472299

Group type: EXPERIMENTAL
Intervention: HiFocusTM Mid-Scala (HFMS) electrode
Number of subjects: 19

Group type: COMPARATOR
Intervention: HiFocusTM 1j (HF1j) electrode
Number of subjects: 19
Study: 26048319

Group type: EXPERIMENTAL
Intervention: Home-based intervention
Number of subjects: 280
Study: 23507723

Group type: EXPERIMENTAL
Intervention: Higher positive end-expiratory pressure (12 ± 2 cm H2O)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lower positive end-expiratory pressure (7 ± 2 cm H2O)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lower pressure support ventilation (3 ± 2 cm H2O)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Resting pressure support ventilation (12 ± 3 cm H2O)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PaO2/FIO2 ratios
Number of subjects: 10
Study: 21558030

Group type: EXPERIMENTAL
Intervention: Supervised Strength Training (ST) for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Supervised Walking Training (WT) for 12 weeks
Number of subjects: 30
Study: 20006031

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted anorectal pull through (LAARP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Posterior sagittal anorectoplasty (PSARP)
Number of subjects: 23
Study: 16022803

Group type: EXPERIMENTAL
Intervention: Electrically stimulated gracilis neosphincter surgery (ESGNS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison groups (not undergoing ESGNS)
Number of subjects: 0
Study: 12137822

Group type: COMPARATOR
Intervention: No local anesthesia (group 1)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Anesthetic block of the prostatic plexus (group 2)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Local anesthesia onto the capsula of the apex (group 3)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Combination of anesthesia used for groups 2 and 3 (group 4)
Number of subjects: 187
Study: 10102792

Group type: EXPERIMENTAL
Intervention: 10 microg/kg rhIL-10
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7775629

Group type: EXPERIMENTAL
Intervention: 30 micrograms EE plus 3 mg DRSP (group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 20 micrograms EE plus 3 mg DRSP (group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 15 micrograms EE plus 3 mg DRSP (group C)
Number of subjects: 80

Group type: COMPARATOR
Intervention: 30 micrograms EE plus 150 micrograms levonorgestrel (Microgynon, group D)
Number of subjects: 80
Study: 2407755

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 52

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 7457946

Group type: EXPERIMENTAL
Intervention: Fentanyl citrate (0.0015, 0.003, 0.006 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine chlorhydrate (0.100, 0.150, 0.200 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fentanyl citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine chlorhydrate
Number of subjects: 0
Study: 31051279

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted seasonal trivalent inactivated influenza vaccine (aIIV3)
Number of subjects: 373

Group type: COMPARATOR
Intervention: Non-adjuvanted inactivated influenza vaccine (IIV3)
Number of subjects: 373
Study: 28080325

Group type: EXPERIMENTAL
Intervention: Packed lunches
Number of subjects: 607

Group type: COMPARATOR
Intervention: Consumed lunches
Number of subjects: 607
Study: 26092515

Group type: EXPERIMENTAL
Intervention: silexan® (WS® 1265, lavender oil)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: WS® 5570 (Hypericum extract)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EGb 761® (Ginkgo biloba extract)
Number of subjects: 12
Study: 23765693

Group type: EXPERIMENTAL
Intervention: Disease-specific enteral nutrition Supportan® containing EPA+DHA
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard enteral nutrition (control group)
Number of subjects: 111
Study: 22082794

Group type: EXPERIMENTAL
Intervention: Combination of all training methods (A)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Heavy-resistance training using full-squat exercise (B)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Power-oriented strength training using parallel-squat exercise (C)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Power-oriented strength training using loaded countermovement jumping (D)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Plyometric jumping (E)
Number of subjects: 65
Study: 19523796

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study: 17846072

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 30
Study: 15217304

Group type: EXPERIMENTAL
Intervention: Intravenous oxycodone (0.1 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intramuscular oxycodone (0.1 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Buccal oxycodone (0.1 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gastric oxycodone (0.1 mg/kg)
Number of subjects: 40
Study: 11802453

Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling (one brief individual counseling session and 4 follow-up telephone calls)
Number of subjects: 228
Study: 9611670

Group type: EXPERIMENTAL
Intervention: Ketamine (0.12 mg/kg bolus and 0.65 mg/kg/hour)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 10
Study: 7922759

Group type: EXPERIMENTAL
Intervention: 1,200 mg of artemisinine daily for 5 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: 750 mg of mefloquine plus 45 mg of primaquine as a single dose
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 27
Study: 2838294

Group type: COMPARATOR
Intervention: Metoclopramide and dexamethasone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nabilone and prochlorperazine
Number of subjects: 80
Study: 29393818

Group type: COMPARATOR
Intervention: Normal saline (group I)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 30 mg of 0.75% ropivacaine (group II)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 30 mg of 0.75% ropivacaine with 100 μg fentanyl (group III)
Number of subjects: 75
Study: 28594758

Group type: EXPERIMENTAL
Intervention: Early insertion of etonogestrel implant (up to 48 hours postpartum)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional insertion of etonogestrel implant (at 6 weeks postpartum)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Early insertion of etonogestrel implant
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional insertion of etonogestrel implant
Number of subjects: 100
Study: 25268386

Group type: EXPERIMENTAL
Intervention: Sarpogrelate (100 mg bid; total dose of 200 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sarpogrelate pretreatment (100 mg tid for three days)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Metoprolol (100 mg) alone
Number of subjects: 9
Study: 24030452

Group type: EXPERIMENTAL
Intervention: Ear acupressure (EAP) for smoking cessation, treated once a week for 8 weeks after a 2-week run-in period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonspecific EAP treatments, treated once a week for 8 weeks after a 2-week run-in period.
Number of subjects: 0
Study: 21935818

Group type: EXPERIMENTAL
Intervention: Trigger point injection combined with stabilization splint (SS) therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stabilization splint (SS) therapy
Number of subjects: 50
Study: 18066916

Group type: EXPERIMENTAL
Intervention: Loss-framed message
Number of subjects: 140

Group type: COMPARATOR
Intervention: Gain-framed message
Number of subjects: 140
Study: 16875158

Group type: EXPERIMENTAL
Intervention: 6.5 million KIU aprotinin
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 2 million KIU aprotinin
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 12228010

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) by needle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) by jet injection (Biojector®)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular/intradermally (ID) by jet injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 11910660

Group type: COMPARATOR
Intervention: Conjugated equine estrogen 0.625 mg, selective estrogen receptor modulator (two doses), or placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hysteroscopy and endometrial biopsy
Number of subjects: 48
Study: 7473012

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (S)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Scaling and root planing plus tetracycline fiber for 10 days (SF)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Fiber therapy alone for 10 days (F)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Two 10‐day serial fiber applications (FF)
Number of subjects: 122

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 122
Study: 1683184

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 30
Study: 6800809

Group type: EXPERIMENTAL
Intervention: Antipyrine (1200 mg daily for 14 days)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Phenobarbital (100 mg daily for 14 days)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rifampicin (1200 mg daily for 14 days)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rifampicin (1200 mg daily for 14 days) with injected 125I-T4
Number of subjects: 7
Study: 31483961

Group type: EXPERIMENTAL
Intervention: SAGE-217 (30 mg once daily)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 27278394

Group type: EXPERIMENTAL
Intervention: Bipolar sealer (BS group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard electrocautery (control group)
Number of subjects: 50
Study: 25495357

Group type: EXPERIMENTAL
Intervention: Behavior modification (low-intensity)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Behavior modification (high-intensity)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.30 mg/kg)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.60 mg/kg)
Number of subjects: 222

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 222
Study: 24119607

Group type: EXPERIMENTAL
Intervention: Lidocaine + adrenaline
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 2% Prilocaine
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 0.25% Bupivacaine
Number of subjects: 140

Group type: COMPARATOR
Intervention: 0.9% Saline (Control)
Number of subjects: 140
Study: 21306863

Group type: EXPERIMENTAL
Intervention: Magnetic acupressure at the LI4 acupoint
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham site
Number of subjects: 77
Study: 20031860

Group type: COMPARATOR
Intervention: No angina (score 100)
Number of subjects: 5460

Group type: EXPERIMENTAL
Intervention: Monthly angina (score 61 to 99)
Number of subjects: 5460

Group type: EXPERIMENTAL
Intervention: Weekly angina (score 31 to 60)
Number of subjects: 5460

Group type: EXPERIMENTAL
Intervention: Daily angina (score 0 to 30)
Number of subjects: 5460
Study: 18187379

Group type: EXPERIMENTAL
Intervention: Group 1 (classical hemodynamic criteria)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Group 2 (LVEF, FS, CI values)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LVEF >30%
Number of subjects: 100

Group type: COMPARATOR
Intervention: FS >20%
Number of subjects: 100

Group type: COMPARATOR
Intervention: CI >2.4 L/min per m2
Number of subjects: 100
Study: 14966771

Group type: EXPERIMENTAL
Intervention: Resistance training (EX, n=19) for 3 months, mainly isokinetic (hydraulic) ergometry.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual care (CON, n=20).
Number of subjects: 39